Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target

Greenman RL, Schein RMH, Martin MA, Wenzel RP, MacIntyre NR, Emmanuel G, Chmel H, Kohler RB, McCarthy M, Plouffe J, Russell JANR, Elena H, Richard I, Michael P, Carol S, Peter J, Alison H, Dawn R, Patricia E, Jill I, Shakti N, Rashkin JE, Jacobs RA, Jacqueline O, Rebecca C, Kenyon VS, Yangco BG, Toney JF, John E, Mark C, Quenzer RW, Trenholme GM, Schmitt BA, Grossman JE, Daley CL, Chambers HF, Iannini PB, Thomas G, Ronald D, Gary S, Mark K, Pankey GA, Brenda M, Sandra A-K, James Z, Michael M, Jeffrey C, Sanders CV, Lance George W, et al. 1991. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266:1097–1102.

留言 (0)

沒有登入
gif